Over 8 million adults in the U.S. experience plaque psoriasis — a chronic autoimmune disease that causes painful, raised, scaly spots on the skin. People with plaque psoriasis often employ a host of ...

Otezla (apremilast) is an oral tablet commonly used to treat plaque psoriasis in adults and children. Plaque psoriasis is an inflammatory skin condition that causes itchy, painful patches on the skin.

STEPIn enrolled systemic- and phototherapy-naïve adults with plaque psoriasis ≤1 year and randomized secukinumab 300 mg versus nb-UVB for 52 weeks, then observed off-treatment to week 104. Off-therapy ...

Alisha Bridges, 36, knows what it feels like to be treated differently because of how she looks. Since elementary school, Alisha has struggled with severe plaque psoriasis—a condition which causes ...

—A growing body of evidence has revealed several comorbidities associated with generalized plaque psoriasis. A new study takes a closer look at possible shared risks for a subtype, palmoplantar ...

Psoriasis is associated with an increased prevalence of high-risk coronary plaques and risk of future cardiovascular events. In a retrospective observational study, lipid rich necrotic core (LRNC), a ...

Dr Mark Lebwohl explains disease burden for patients with plaque psoriasis and discusses the common comorbidities clinicians see. Ryan Haumschild, PharmD, MS, MBA: I'm interested, Dr Lebwohl, on ...

Portia has not taken Sotyktu. Portia Brown* has long been drawn toward helping people cope with challenges. Since volunteering as a college student to work with her peers to educate them about sexual ...

A review highlights new and emerging treatments for generalized pustular psoriasis, with a focus on IL-36 inhibitors.

Otezla is the first oral therapy approved for moderate to severe plaque psoriasis in this patient population. The Food and Drug Administration (FDA) has expanded the approval of Otezla ® (apremilast) ...

Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including ...

Psoriasis treatments have been a staple of TV advertising for nearly 50 years. That’s because the skin disease is relatively widespread throughout the United States. Roughly 80 to 90 percent of ...